Zofran odt and Ultram drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zofran odt (ondansetron) and Ultram (tramadol hydrochloride). Common drug interactions include fatigue among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Zofran odt and Ultram. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Zofran odt?

Zofran odt has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 2,092 Zofran odt users. Check the latest studies of Zofran odt.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.



On Jul, 07, 2026

33 people who take Zofran odt and Ultram together, and have interactions are studied.

Zofran odt and Ultram drug interactions.

What are the common drug interactions of Zofran Odt and Ultram, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Pain in extremity
  3. Disease progression
  4. Nervousness
  5. Pericardial effusion (fluid around the heart)
  6. Peripheral swelling
  7. Pleural effusion (water on the lungs)
  8. Accident
  9. Nerve injury
  10. Bone pain

male:

  1. Asthenia (weakness)
  2. Blood glucose increased
  3. Fatigue (feeling of tiredness)
  4. Migraine (headache)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Chronic kidney disease
  8. Chronic myelomonocytic leukaemia (cancers of the blood-forming cells of the bone marrow)
  9. Decreased appetite
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Zofran Odt and Ultram, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Headache (pain in head)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Drug ineffective
  5. Drug resistance (reduction in effectiveness of a drug)
  6. Emotional distress
  7. Foot fracture
  8. Hand fracture
  9. Renal failure (kidney dysfunction)
  10. Renal impairment (severely reduced kidney function)

30-39:

  1. Asthenia (weakness)
  2. Bone pain
  3. Cardiomyopathy (weakening of the heart muscle)
  4. Constipation
  5. Dysgeusia (disorder of the sense of taste)
  6. Fatigue (feeling of tiredness)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Metastases to skin (cancer spreads to skin)
  9. Mobility decreased (ability to move is reduced)
  10. Nervous system disorder (a general class of medical conditions affecting the nervous system)

40-49:

  1. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  2. Urinary tract infection

50-59:

  1. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  2. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  3. Abdominal pain upper
  4. Diarrhoea
  5. Fatigue (feeling of tiredness)

60+:

  1. Disease progression
  2. Nervousness
  3. Insomnia (sleeplessness)
  4. Blood glucose increased
  5. Discomfort
  6. Glycosylated haemoglobin increased
  7. Headache (pain in head)
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Visual impairment
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Nausea And Vomiting: 7 people, 21.21%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 15.15%
  3. Blood Pressure Abnormal: 5 people, 15.15%
  4. Neuralgia (pain in one or more nerves): 5 people, 15.15%
  5. Nerve Injury: 5 people, 15.15%
  6. Multiple Myeloma (cancer of the plasma cells): 5 people, 15.15%
  7. Depression: 5 people, 15.15%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 12.12%
  9. Cryptococcosis (potentially fatal fungal disease): 3 people, 9.09%
  10. Hiv Infection: 3 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Zofran odt and Ultram?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zofran odt and Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zofran odt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zofran odt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ultram and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ondansetron and tramadol hydrochloride (the active ingredients of Zofran odt and Ultram, respectively), and Zofran odt and Ultram (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: